Catalyst Pharmaceutical Partners Inc $2.07
|Trade Time:||Mar 10 05:20 PM Eastern Daylight Time|
|Change:||-0.10 (-4.61 %)|
Quotes displayed are delayed by 15 minutes. Market data is provided by Xignite
Get CPRX Trend Analysis - it has outperformed the S&P 500 by 358%
|No ETF alternatives available.|
|Date||Name||Title||Volume||Trade Price||Holding Change|
|2/07/2014||MCENANY PATRICK J||President and CEO||25,000||$1.82||0.69%|
|2/05/2014||O'Keeffe Charles B||Director||10,000||$1.81||5.98%|
|10/23/2013||Tierney David S||Director||8,000||$2.03||3.89%|
|10/21/2013||O'Keeffe Charles B||Director||10,000||$1.84||6.36%|
|10/21/2013||MCENANY PATRICK J||President and CEO||50,000||$1.60||1.41%|
CPRX Stock Analysis
- No results found.
Get the four benefits of managed futures as outlined in this booklet.
Learn from Warren Buffett, George Soros and More!
Discover Investing Strategies that will Benefit Every Investor Today!